EquipNet India Celebrates 10 Years
EquipNet India, a subsidiary of EquipNet, a laboratory equipment supplier, celebrated its 10th anniversary in the surplus asset management market.
On Sep. 18, 2017, EquipNet India, a subsidiary of EquipNet, a laboratory equipment supplier, celebrated its 10th anniversary in the surplus asset management market. The Indian subsidiary has been operating from its Mumbai headquarters since 2007.
“Surplus asset management is being recognized as increasingly critical, and many companies realize that they do not have the resource or skill base to tackle the issue in-house,” said Krishnamoorthy Vishwanathan, managing director of EquipNet India, in a company press release. “Choosing when to invest internal resources in a specific activity and when to seek external help is a tough, but essential, management task. Defining and focusing on core company strengths and recognizing the need for expert support in other areas will ensure operational efficiency and can have a major impact on the bottom line.”
According to an IBEF report, the Indian market has experienced an almost 8% growth rate from 2016 to 2017. By 2020, it is estimated that India will become the fifth largest manufacturing country in the world, creating 100 million new jobs by 2022.
Source: Equipnet
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.
In Wake of Trump Tariffs, Lilly Plans New US Pharmaceutical Manufacturing Sites
February 26th 2025Previous domestic capital expansion commitments since 2020 had been made in Research Triangle Park and Concord, both in North Carolina; Kenosha County, Wisconsin; Lebanon, Indiana; and Lilly’s home city of Indianapolis.
Cosette Pharmaceuticals Adds to Dermatology and Women’s Health Portfolio with Mayne Pharma Purchase
Published: February 26th 2025 | Updated: February 26th 2025While the boards of directors of both companies have approved the transaction, it is not expected to close until the second quarter of 2025, as Mayne Pharma’s shareholders must still vote in favor of the acquisition.
